Using mathematical quantification of limb and eye movement of Parkinson's disease patients as a biomarker for classification and prediction of disease state and response to treatment.

Principal Investigator

Anas Hannoun

Study Number

STUDY02002335

Summary

This is a three-armed open investigational study that aims to differentiate, quantify, and categorize abnormal eye movements and upper limbs movements in patients with Parkinson's disease. The study is using investigational non-invasive devices for that reason including ANLIVA® Hand Movement and ANLIVA® Eye Movement.

Phase

Pilot/Feasibility

Available at the following location(s)

• Lebanon

View more details at ClinicalTrials.gov

Do you need help with some of the labels on this page?
Read our glossary of terms